New York drug distributor exits opioids after admitting role in crisis

Rochester Drug Co-Operative (RDC), a New York company that was the first drug distributor to face U.S. felony charges for its role in fueling the opioid crisis, said on Tuesday it will stop distributing controlled pharmaceuticals, which include opioids.

Rochester Drug Co-Operative (RDC), a New York company that was the first drug distributor to face U.S. felony charges for its role in fueling the opioid crisis, said on Tuesday it will stop distributing controlled pharmaceuticals, which include opioids. RDC announced the decision after agreeing last April to settle the charges by paying a $20 million fine and accepting independent monitoring, under a 5-year deferred prosecution agreement. Controlled pharmaceuticals represent a relatively small percentage of RDC's sales, but the company cited "significant legal and compliance expenses," and said that those costs are "simply not sustainable." The company will continue to distribute non-controlled, generic, and private label drugs, as well as health care supplies. It said it serves 1,300 community pharmacies, long-term care pharmacies, and home health care stores.